{
    "nctId": "NCT03164863",
    "briefTitle": "Onco4D(TM) Biodynamic Chemotherapy Selection for Breast Cancer Patients",
    "officialTitle": "Feasibility Study of Motility Contrast Tomography for Predicting Therapeutic Response",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Objective pathological response measured at the time of surgery.",
    "eligibilityCriteria": "INCLUSION CRITERIA: To be eligible for the study, women must meet the following criteria:\n\n1. Ability to understand and willingness to sign an informed consent and authorization for release of tissue not required for pathologic diagnosis to be used for research purposes\n2. \u2265 18 years old at time of consent\n3. Patients with all or any combination of the following indications to include diagnosis of breast cancer, abnormal mammography, abnormal ultrasound, with or without abnormal clinical findings as well as abnormal clinical findings without an imaging correlate.\n\nEXCLUSION CRITERIA: To be eligible for the study, women must not be or have any of the following:\n\n1. Women who are pregnant or breastfeeding\n2. Known tumor genetics or other factors, which in the treating physician's professional judgement, make the patient an unlikely candidate to receive chemotherapy (either neoadjuvantly or adjuvantly)",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}